Esophagus Cancer Completed Phase 1 / 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00193128Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus CancerTreatment